NL-OMON23731RecruitingNot Applicable
A prospective, randomised controlled multi-centre trial comparing in-hospital treatment and early assisted discharge for exacerbations of Chronic Obstructive Pulmonary Disease (COPD).
niversity Maastricht (UM), CAPHRI instituteiMTA, Erasmus MC Rotterdam0 sites235 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 235
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Age 40 and older;
- •2. Competent;
Exclusion Criteria
- •1. Major uncontrolled co-morbidity;
- •2. Mental disability;
Investigators
Similar Trials
Terminated
Phase 4
Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice ForielleInfertilityNCT03387059Merck KGaA, Darmstadt, Germany9
Active, not recruiting
Not Applicable
se of the corifolitropina alfa in oocyte donorsThe study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation programEUCTR2014-001743-20-ESIVI Madrid
Completed
Not Applicable
Mycophenolate sodium vs Everolimus or Ciclosporin with Allograft Nephropathy as Outcome.prospective, open, randomized multicenterNL-OMON25640MECANO Steering group Chair: S.Surachno/F.Bemelman255
Recruiting
Not Applicable
A prospective, open-label, multicenter randomized phase-II trial to evaluate the efficacy and safety of a sequential regimen of obinutuzumab (Gazyvaro) followed by obinutuzumab and venetoclax, followed by either standard venetoclax maintenance or MRD guided venetoclax maintenance in first-line patients with CLL and unfit for FCR-like regimensChronic Lymphocytic Leukemia (CLL)NL-OMON23205HOVON data center70
Active, not recruiting
Not Applicable
A prospective, randomised, multicenter clinical trial investigating the reduction of Calcineurin inhibitor toxicity by means of steroid free long-term immune suppression with Ciclosporin A and Mycophenolat mofetil in children and adolescents after kidney transplantation - Recaltox-1EUCTR2007-001166-33-DEniversitaetsklinikum Erlangen-Nuernberg